0001681682-25-000004.txt : 20251024 0001681682-25-000004.hdr.sgml : 20251024 20251024160237 ACCESSION NUMBER: 0001681682-25-000004 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06c FILED AS OF DATE: 20251024 DATE AS OF CHANGE: 20251024 EFFECTIVENESS DATE: 20251024 FILER: COMPANY DATA: COMPANY CONFORMED NAME: ENDRA Life Sciences Inc. CENTRAL INDEX KEY: 0001681682 STANDARD INDUSTRIAL CLASSIFICATION: ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845] ORGANIZATION NAME: 08 Industrial Applications and Services EIN: 260579295 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-562053 FILM NUMBER: 251416147 BUSINESS ADDRESS: STREET 1: 3600 GREEN COURT STREET 2: SUITE 350 CITY: ANN ARBOR STATE: MI ZIP: 48105 BUSINESS PHONE: 734-335-0468 MAIL ADDRESS: STREET 1: 3600 GREEN COURT STREET 2: SUITE 350 CITY: ANN ARBOR STATE: MI ZIP: 48105 FORMER COMPANY: FORMER CONFORMED NAME: Endra Inc. DATE OF NAME CHANGE: 20160805 D 1 primary_doc.xml X0708 D LIVE 0001681682 ENDRA Life Sciences Inc. 3600 GREEN COURT SUITE 350 ANN ARBOR MI MICHIGAN 48105 734-335-0468 DELAWARE Endra Inc. Corporation true Alexander Tokman 3600 GREEN COURT SUITE 350 Ann Arbor MI MICHIGAN 48105 Executive Officer Director Michael Thornton 3600 GREEN COURT SUITE 350 Ann Arbor MI MICHIGAN 48105 Executive Officer Richard Jacroux 3600 GREEN COURT SUITE 350 Ann Arbor MI MICHIGAN 48105 Executive Officer Louis J. Basenese 3600 GREEN COURT SUITE 350 Ann Arbor MI MICHIGAN 48105 Director Anthony DiGiandomenico 3600 GREEN COURT SUIUTE 350 Ann Arbor MI MICHIGAN 48105 Director Michael Harsh 3600 GREEN COURT SUITE 350 Ann Arbor MI MICHIGAN 48105 Director Biotechnology No Revenues 06c false 2025-10-10 false true true Prefunded and Common Warrants to purchase shares of Common Stock false 200000 Lucid Capital Markets, LLC 000140345 None None 570 Lexington Avenue, 40th Floor New York NY NEW YORK 10022 CT CONNECTICUT AZ ARIZONA NY NEW YORK false 14402880 14402880 0 Reflects proceeds from the sale of shares of the Company's common stock, par value $0.0001 per share and/or pre-funded warrants and common stock purchase warrants, if all such warrants were exercised. false 6 295498 0 0 false ENDRA Life Sciences Inc. /s/ Alexander Tokman Alexander Tokman Chief Executive Officer 2025-10-24